SSc Autoantibody Identified with Link to GI Dysfunction : vi

If validated as a biomarker, anti-gephyrin autoantibodies could help identify patients at higher risk for GI symptoms like constipation.

Related Keywords

Maryland , United States , Texas , Hospital For Special Surgery , New York , Subhash Kulkarni , Zsuzsannah Mcmahan , Kimberly Lakin , Johns Hopkins University In Baltimore , Weill Cornell Medical College , Johns Hopkins Scleroderma Center , Medscape Medical News , Johns Hopkins University , Special Surgery , New York City , Texas Health Science Center , Scleroderma , Crest Syndrome , Constipation , Systemic Sclerosis , Diffuse Scleroderma , Bloating , Biomarker , Iological Marker , Gastrointestinal Disease , Di Disease , Nerve Cell , Arthritis , Oint Inflammation , Hospitals , Immunohistochemistry , Mass Spectrometry , Nerves , Preventive Screening , Screening , Surgery , Biologic Therapy ,